Pillai S. – Page 2 – TechConnect Briefs

Silver Coated Carbon Nanotubes Inhibit RSV Infection

Adiani L., Subbarayan P., Boyoglu S., Vig K., Pillai S., Rangari V., Singh S.R., Alabama State University, US

Respiratory Syncytial Virus (RSV) is a member of the genus Pneumovirus in the family of Paramyxoviridae. It is one of the most common causes of upper and lower respiratory tract infections, bronchiolitis and pneumonia worldwide [...]

Respiratory Syncytial Virus Inhibition by Gold and Titanium Nanoparticles

Vig K., Boyoglu S., Rangari V., Pillai S., Singh S.R., Alabama State University, US

Respiratory Syncytial Virus (RSV) is the leading cause of severe respiratory illnesses including bronchiolitis and pneumonia in young children. The RSV surface proteins F (fusion) and G (attachment) are major targets for vaccine development against [...]

Evaluation of Nanoencapsulated DNA Vaccine for RSV

Boyoglu S., Vig K., Rangari V., Pillai S., Dennis V., Singh S.R., Alabama State University, US

Polymer nanoparticles have been used as carriers to enhance drug delivery. Among them chitosan is the most commonly used carrier, because it promotes long term of incorporated drugs. In the present study,we used DNA vaccine [...]

Use of Nanoparticles as Therapy for Respiratory Syncytial Virus Inhibition

Vig K., Boyoglu S., Rangari V., Sun L., Singh A., Singh S.R., Pillai S., Singh A., Singh S.R., Alabama State University, US

Respiratory Syncytial Virus is the leading cause of severe respiratory illnesses such as bronchiolitis and pneumonia in young children. RSV is a paramyxovirus with negative-sense genomic RNA that encodes for eleven proteins, two of which, [...]